JAN 29, 2016 5:22 PM PST

Blood Pressure Drug May Be Answer to Alzheimer's Disease

WRITTEN BY: Julianne Chiaet
Alzheimer's disease primarily affects individuals over age 65.A drug used to treat high blood pressure could be the answer to treating and preventing Alzheimer’s disease.

Alzheimer’s disease is a progressive degenerative brain disease. It causes cognitive decline and memory loss. In Alzheimer’s disease, damaged cells release too much glutamate, an important neurotransmitter involved in most aspects of brain function. The excess glutamate leads to chronic overexposure to calcium, which in turn speeds up brain cell damage.

Using neuronal cultures, the researchers studied the effects of the high blood pressure medication on the toxic effects of excessive glutamate. The medication, candesartan, is an angiotensin receptor blocker sold under the brand name Atacand.

The researchers found that candesartan prevented neuronal death caused by glutamate. The drug also prevented neuronal inflammation and changes in amyloid metabolism. The latter change is especially important since the buildup of amyloid plaques are a hallmark of the disease. The researchers then compared the gene expression in the cultures to autopsy samples from Alzheimer’s patients that were published in gene databases.
 

"The correlations were impressive. The expression of 471 genes that were altered by excess glutamate in our cultures were also altered in brain autopsy samples from patients who suffered from Alzheimer's disease. Candesartan normalized expression of these genes in our cultures," said study author Abdel G. Elkahloun, from the Comparative Genomics and Cancer Genetics Branch of the National Human Genome Research Institute.

The researchers hypothesize that candesartan and/or other angiotensin receptor blockers have the potential to slow down the progression of Alzheimer’s and prevent or delay its development.
They say their findings support testing candesartan and other angiotensin receptor blockers in controlled clinical studies on patients at early stages of Alzheimer’s.

The research was published online on January 28, 2016, in the journal Alzheimer’s Research and Therapy.

Sources: Journal study Alzheimer’s Research and Therapy, Georgetown University Medical Center press release

 
About the Author
  • Julianne (@JuliChiaet) covers health and medicine for LabRoots. Her work has been published in The Daily Beast, Scientific American, and MailOnline. While primarily a science journalist, she has also covered culture and Japanese organized crime. She is the New York Board Representative for the Asian American Journalists Association (AAJA). • To read more of her writing, or to send her a message, go to Jchiaet.com
You May Also Like
JUL 14, 2020
Clinical & Molecular DX
The Smell of Rotten Fish Could Help Predict the Recovery of Unresponsive Patients
JUL 14, 2020
The Smell of Rotten Fish Could Help Predict the Recovery of Unresponsive Patients
A study published in the journal Nature provides new evidence supporting an unconventional test to map recovery paths of ...
JUL 19, 2020
Microbiology
A Hybrid Fungus Is Linked to Lung Infections
JUL 19, 2020
A Hybrid Fungus Is Linked to Lung Infections
A type of fungus that's been found in soil or plants has now been identified in a hospital environment and in people for ...
JUL 22, 2020
Clinical & Molecular DX
Unmasking the Secrets of the Substantia Nigra to Diagnose Parkinson's
JUL 22, 2020
Unmasking the Secrets of the Substantia Nigra to Diagnose Parkinson's
Parkinson’s disease is a devastating condition whereby neurons in a specific region of the brain that controls mov ...
JUL 30, 2020
Health & Medicine
Navy Goes Overboard on Hemp Ban for Sailors and Marines
JUL 30, 2020
Navy Goes Overboard on Hemp Ban for Sailors and Marines
It may be a federally legal crop, but the Sailors and Marines of the US navy have been told they cannot use hemp in any ...
JUL 31, 2020
Cell & Molecular Biology
To Outsmart Salmonella, Cells Can Commit Suicide in Different Ways
JUL 31, 2020
To Outsmart Salmonella, Cells Can Commit Suicide in Different Ways
When cells are infected with some strains of the Salmonella bacterium, it can cause typhoid fever, which causes the deat ...
AUG 06, 2020
Cardiology
Identifying a Prognostic Biomarker for Neurological Deterioration After a Stroke
AUG 06, 2020
Identifying a Prognostic Biomarker for Neurological Deterioration After a Stroke
Strokes are life-changing events that can cause a myriad of issues even after it is over. Plenty of tests, such as the n ...
Loading Comments...